Titan Pharmaceuticals Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Titan Pharma (TTNP) Tops Q2 EPS by 2c
August 9, 2016 4:56 PM EDTTitan Pharma (NASDAQ: TTNP) reported Q2 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15 million versus the consensus estimate of $15 million.
For earnings history and earnings-related data on Titan Pharma (TTNP) click here.
... More


